Scientific article

Efficacy of rimonabant in obese patients with binge eating disorder

Published inExperimental and clinical endocrinology & diabetes, vol. 121, no. 01, p. 20-26
Publication date2012

In obesity, a dysregulation of the endocannabinoid system has been shown. The endocannabinoid receptor blockage by rimonabant demonstrated interesting metabolic effects. However, the role of rimonabant in weight loss of patients with binge eating disorder has not been investigated. Thus, our aim was to evaluate the effects of rimonabant on body weight in obese patients with binge eating disorders.

  • Endocannabinoid system, Rimonabant, Obesity, Binge eating disorder
Citation (ISO format)
PATAKY, Zoltan et al. Efficacy of rimonabant in obese patients with binge eating disorder. In: Experimental and clinical endocrinology & diabetes, 2012, vol. 121, n° 01, p. 20–26. doi: 10.1055/s-0032-1329957
Main files (1)
Article (Published version)
ISSN of the journal0947-7349

Technical informations

Creation12/05/2013 10:05:00 AM
First validation12/05/2013 10:05:00 AM
Update time03/14/2023 8:44:35 PM
Status update03/14/2023 8:44:35 PM
Last indexation08/29/2023 8:19:57 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack